Showing posts with label
takeover targets
.
Show all posts
Showing posts with label
takeover targets
.
Show all posts
Thursday, March 20, 2025
We've been adding to our Chargepoint position under a buck. Here are some reasons why we like CHPT stock
›
ChargePoint Holdings Inc. (CHPT) remains a significant player in the electric vehicle (EV) charging industry, but it faces both challenges...
Tuesday, February 4, 2025
Takeover Targets: As 2025 rolls out and acquisitions begin to take hold, we list (speculatively) 12 possibilities of acquisitions in the Tech and Healthcare sector!
›
Below is a high‐level informational look at potential suitability as a takeover/acquisition targets, along with a very rough ranking from...
Wednesday, January 22, 2025
Who might be interested in Acquiring Chargepoint's EV charging network?
›
Feb 11th 2025 We have been "Stopped out" of Chargepoint shares. O U C H !!! Sometimes speculation can hurt! (even if it's jus...
Wednesday, October 9, 2024
While speculating on possible BioTech takeover targets, Ginkgo Bioworks jumped off the page, keeping in mind that speculation is a double edged sword!
›
Ginkgo Bioworks is recognized as a leader in synthetic biology, specializing in the design and programming of custom organisms for a varie...
Wednesday, June 19, 2024
Interest in Quantum computing technology is growing. Should there be consolidation in the quantum space, one company stands out as a takeover target!
›
Acquiring IONQ could be appealing to larger companies for several reasons related to its trapped ion quantum technology. Here are some key ...
Thursday, June 13, 2024
Consolidation in the BioTech realm is a given going forward. Ginkgo Bioworks technology looks attractive to larger companies in the space!
›
Ginkgo Bioworks, a prominent player in the synthetic biotech market, could be a potential target for acquisition or merger, especially if co...
Thursday, May 23, 2024
As Healthcare and Biotech companies utilize cutting edge Ai technology, more and more diseases will be conquered.
›
Let’s take a look at the treatments offered by three, up and coming, BioTech companies with cutting edge therapies, that are currently on ...
›
Home
View web version